Employment and work ability in individuals living with rare diseases: a systematic literature review
Open Access
- 23 April 2025
- journal article
- review article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 20 (1) , 1-20
Abstract
Background: The socioeconomic impact of rare diseases has been mostly studied at the macrolevel, but evidence at the microlevel is lacking, which overshadows health-related social inequalities affecting people with rare diseases, namely, health selection effects. Aim: This study presents an overview of employment and work ability in individuals living with rare diseases, two factors related to health selection effects. Methods: A systematic literature review was conducted using the PRISMA checklist. Three electronic databases, PubMed, Embase, and Web of Science, were searched from 2013 to 2023. Eligible studies needed to investigate at least one work-related outcome measuring employment or work ability in individuals living with rare diseases and to compare it with a control group. Indeed, including only studies with matched or standardized control groups is essential for ensuring the reliability and validity of research findings. Results: Of the 7,694 abstracts identified, 44 studies, including 34 rare diseases, met the inclusion criteria. Administrative databases were used to collect work-related data in 48% of the studies, and 73% of the studies employed matching methods for comparison. Overall, 52% of the studies focused solely on employment, 14% focused solely on work ability and 34% included both categories. Individuals with rare diseases were less likely to be employed or more likely to be unemployed than controls in 68% of the studies and 87% of the studies reported that individuals with rare diseases were more likely to be work disabled. Regarding work ability, 90% of the studies reported more missed work time in cases than in controls, and more perceived impairment at work was found in 100% of the studies. Discussion/conclusion: These results show that individuals with rare diseases tend to have poor work outcomes, but methodological limitations hamper the understanding of health selection effects. Implications for future research and policy-making are discussed.Keywords
Funding Information
- Horizon 2020 Framework Programme (EJP RD COFUND-EJP N° 825575)
- Agence Nationale de la Recherche
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Instituto de Salud Carlos III
- Fonds Wetenschappelijk Onderzoek
This publication has 78 references indexed in Scilit:
- Societal costs associated with pulmonary arterial hypertension: A study utilizing linked national registriesPulmonary Circulation, 2023
- Work productivity impairment in patients with familial Mediterranean fever and effects of interleukin-1 antagonistsClinical Rheumatology, 2021
- Excess Productivity Costs of Systemic Lupus Erythematosus, Systemic Sclerosis, and Sjögren's Syndrome: A General Population–Based StudyArthritis Care & Research, 2018
- Impact of early systemic lupus erythematosus on work disability—results from the Finnish nationwide register 2000–2007Clinical Rheumatology, 2018
- Social/economic costs and health-related quality of life in patients with rare diseases in EuropeThe European Journal of Health Economics, 2016
- Rare is frequent and frequent is costly: rare diseases as a challenge for health care systemsThe European Journal of Health Economics, 2014
- Health, social and economic consequences of hypersomnia: a controlled national study from a national registry evaluating the societal effect on patients and their partnersThe European Journal of Health Economics, 2013
- Quality of life in rare genetic conditions: A systematic review of the literatureAmerican Journal of Medical Genetics Part A, 2010
- Work disability associated with cancer survivorship and other chronic conditionsPsycho-Oncology, 2007
- Depression and unemployment: Panel findings from the Epidemiologic Catchment Area studyAmerican Journal of Community Psychology, 1994